| Literature DB >> 29311131 |
Ian Ahearn1, Mo Zhou1, Mark R Philips1.
Abstract
The three human RAS genes encode four proteins that play central roles in oncogenesis by acting as binary molecular switches that regulate signaling pathways for growth and differentiation. Each is subject to a set of posttranslational modifications (PTMs) that modify their activity or are required for membrane targeting. The enzymes that catalyze the various PTMs are potential targets for anti-RAS drug discovery. The PTMs of RAS proteins are the focus of this review.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29311131 PMCID: PMC6035883 DOI: 10.1101/cshperspect.a031484
Source DB: PubMed Journal: Cold Spring Harb Perspect Med ISSN: 2157-1422 Impact factor: 6.915